Pharmaceutical Business review

Meridian closes private placement financing

The company said that proceeds from the financing will be used to reduce the debt load of the company and to fund its marketing program in North America and Europe. No investment bank or financial advisor was used in the transaction. The company’s management team arranged and closed the transaction.

The private placement shares represent approximately 6% of the 33 million shares of the common stock of the company issued and outstanding on the date of the private placement.